NBW Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-35,229
| Closed | -$2.62M | – | 91 |
|
|
2022
Q2 | $2.62M | Sell |
35,229
-48,822
| -58% | -$3.63M | 0.72% | 65 |
|
|
2022
Q1 | $7.56M | Sell |
84,051
-1,035
| -1% | -$93K | 1.79% | 16 |
|
|
2021
Q4 | $9.53M | Buy |
85,086
+2,991
| +4% | +$335K | 2.12% | 9 |
|
|
2021
Q3 | $10.3M | Buy |
82,095
+6,818
| +9% | +$857K | 2.49% | 6 |
|
|
2021
Q2 | $10.2M | Buy |
75,277
+5,196
| +7% | +$704K | 2.48% | 8 |
|
|
2021
Q1 | $9.51M | Buy |
70,081
+6,054
| +9% | +$821K | 2.62% | 8 |
|
|
2020
Q4 | $9.01M | Sell |
64,027
-3,620
| -5% | -$510K | 2.74% | 7 |
|
|
2020
Q3 | $7.54M | Buy |
67,647
+5,649
| +9% | +$629K | 2.51% | 11 |
|
|
2020
Q2 | $6.94M | Sell |
61,998
-14,329
| -19% | -$1.6M | 2.49% | 9 |
|
|
2020
Q1 | $5.91M | Sell |
76,327
-2,051
| -3% | -$159K | 2.82% | 10 |
|
|
2019
Q4 | $7.46M | Buy |
78,378
+538
| +0.7% | +$51.2K | 2.12% | 12 |
|
|
2019
Q3 | $5.94M | Sell |
77,840
-2,600
| -3% | -$198K | 1.76% | 20 |
|
|
2019
Q2 | $7.06M | Buy |
80,440
+1,344
| +2% | +$118K | 1.94% | 14 |
|
|
2019
Q1 | $7.16M | Buy |
79,096
+2,799
| +4% | +$253K | 1.96% | 18 |
|
|
2018
Q4 | $5.47M | Sell |
76,297
-994
| -1% | -$71.3K | 1.94% | 16 |
|
|
2018
Q3 | $7.41M | Buy |
77,291
+3,472
| +5% | +$333K | 1.99% | 16 |
|
|
2018
Q2 | $7.03M | Buy |
73,819
+2,395
| +3% | +$228K | 2.01% | 22 |
|
|
2018
Q1 | $6.27M | Sell |
71,424
-11,451
| -14% | -$1M | 1.96% | 25 |
|
|
2017
Q4 | $7.03M | Buy |
82,875
+33,534
| +68% | +$2.85M | 1.85% | 28 |
|
|
2017
Q3 | $4.27M | Sell |
49,341
-19
| -0% | -$1.65K | 1.16% | 36 |
|
|
2017
Q2 | $3.81M | Buy |
+49,360
| New | +$3.81M | 1.06% | 39 |
|